- Sector
- Client CPI
An innovative research and development facility, supporting the UK's pharmaceutical and fine chemical industries in accelerating a new generation of manufacturing processes.
Innovative research and development facility supporting the UK’s pharmaceutical and fine chemicals industry in accelerating manufacturing processes
Fluid and dynamic design allowing for reconfiguration and expansion
A catalyst project, paving the way for future development on the wider campus
An innovative research, development and manufacturing facility, the new Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire will support the UK’s pharmaceutical and fine chemicals industries in accelerating a new generation of manufacturing processes.
A joint project between CPI, the University of Strathclyde, UK Research and Innovation, Scottish Enterprise, GSK and AstraZeneca, the Centre will provide academics, research scientists and manufacturing partners with access to cutting-edge technical equipment and knowledge. It aims to encourage collaboration to develop new technologies and processes that will increase productivity in medicines manufacturing.
BakerHicks have been supporting CPI and their partners on the project since 2015, facilitating industry-wide stakeholder workshops and evaluated design options to develop the project brief.
In 2019, they were appointed to deliver multi-disciplinary design services, including architecture, civil and structural, mechanical and electrical, pharmaceutical consultancy, and process engineering, to RIBA Stage 3. The team are now working closely with the main contractor to provide a principal designer advisory role as the project progresses towards construction.
European network, local expertise.
